Andrew Saik's Net Worth

$3.35 Million

Estimate Recalculated Sep 9, 2024 12:26AM EST

Who is Andrew Saik

Andrew Saik has an estimated net worth of $3.35 Million. This is based on reported shares across multiple companies, which include INTERCEPT PHARMACEUTICALS, INC., Menlo Therapeutics Inc., Edge Therapeutics, Inc., AUXILIUM PHARMACEUTICALS INC, ARVINAS, INC., and Milestone Pharmaceuticals Inc..

SEC CIK

Andrew Saik's CIK is 0001616284

Past Insider Trading and Trends

2018 was Andrew Saik's most active year for acquiring shares with 3 total transactions. Andrew Saik's most active month to acquire stocks was the month of May. 2023 was Andrew Saik's most active year for disposing of shares, totalling 8 transactions. Andrew Saik's most active month to dispose stocks was the month of October. 2020 saw Andrew Saik paying a total of $49,920.00 for 38,400 shares, this is the most they've acquired in one year. In 2015 Andrew Saik cashed out on 175,000 shares for a total of $6,392,750.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INTERCEPT PHARMACEUTICALS, INC.

EVP & Chief Financial Officer
Updated Nov 13, 2023
Form 4
-100.00%
-182.41K
$19.00
-$1.30M
Nov 13, 2023
Disposition
Nov 08
Form 4
-1.31%
-908.00
$10.80
-$9.81K
Sep 25, 2023
68.27K
Tax
Sep 21
Form 4
-1.30%
-908.00
$11.74
-$10.66K
Jun 23, 2023
69.17K
Tax
Jun 21
Form 4
-1.28%
-909.00
$14.19
-$12.90K
Mar 23, 2023
70.08K
Tax
Mar 21
Form 4
68.75%
38.70K
Jan 31, 2023
94.99K
Grant
Jan 27
Form 4
-1.26%
-718.00
$12.37
-$8.88K
Jan 03, 2023
56.29K
Tax
Dec 31
Form 4
-1.57%
-908.00
$13.43
-$12.19K
Dec 23, 2022
57.01K
Tax
Dec 21
Form 4
-1.54%
-908.00
$14.85
-$13.48K
Sep 23, 2022
57.92K
Tax
Sep 21
Form 4
-5.82%
-3.63K
$12.48
-$45.33K
Jun 23, 2022
58.82K
Tax
Jun 21
Form 4
53.49%
27.90K
Jan 31, 2022
80.06K
Grant
Jan 27
Form 4
124.70K
Jun 22, 2021
124.70K
Grant
Jun 21
Form 3
Jun 22, 2021
Showing 12 results

Menlo Therapeutics Inc.

Chief Financial Officer
Updated Mar 24, 2020
Form 3
Mar 24, 2020
Showing 1 results

Edge Therapeutics, Inc.

Chief Financial Officer
Updated Feb 19, 2020
Form 4
925.52%
38.40K
$1.30
$49.92K
Feb 19, 2020
42.55K
Grant
Feb 14
Form 4
62.72K
Jun 07, 2019
62.72K
Grant
Jun 06
Form 4
Mar 18, 2019
83.00K
Options
Mar 15
Form 4
83.00K
Aug 15, 2018
83.00K
Grant
Aug 14
Form 4
166.00K
Jun 20, 2018
166.00K
Grant
Jun 19
Form 4
50.00K
Mar 05, 2018
50.00K
Grant
Mar 01
Form 4
200.00K
Nov 03, 2017
200.00K
Grant
Nov 01
Form 3
Nov 02, 2017
Showing 8 results

AUXILIUM PHARMACEUTICALS INC

CFO
Updated Jan 30, 2015
Form 4
-100.00%
-175.00K
$36.53
-$6.39M
Jan 30, 2015
Disposition
Jan 29
Form 4
175.00K
Aug 20, 2014
175.00K
Grant
Aug 18
Form 3
Aug 20, 2014
Showing 3 results

ARVINAS, INC.

Chief Financial Officer
Updated Jun 26, 2024
Form 4
155.83K
Jun 26, 2024
155.83K
Grant
Jun 24
Form 3
Jun 26, 2024
Showing 2 results

Milestone Pharmaceuticals Inc.

Investor
Updated Aug 29, 2024
Form 4
40.00K
Aug 29, 2024
40.00K
Grant
Aug 28
Form 4
-50.00%
-80.00K
Jul 17, 2024
80.00K
Grant
Jul 15
Form 3
Jul 17, 2024
Showing 3 results